<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/37EF6C9C-5F51-40DD-BED5-B792981BC119"><gtr:id>37EF6C9C-5F51-40DD-BED5-B792981BC119</gtr:id><gtr:name>Imperial Cancer Research Fund</gtr:name><gtr:address><gtr:line1>44 Lincoln's Inn Fields</gtr:line1><gtr:postCode>WC2A 3PX</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/289F7529-FA9B-42C2-B4C7-4603DA25CC42"><gtr:id>289F7529-FA9B-42C2-B4C7-4603DA25CC42</gtr:id><gtr:name>Ludwig Institute for Cancer Research</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E5AB7E3C-876B-4608-8B8A-C7EC86B34584"><gtr:id>E5AB7E3C-876B-4608-8B8A-C7EC86B34584</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Turner</gtr:surname><gtr:orcidId>0000-0002-3801-9896</gtr:orcidId><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G117%2F424"><gtr:id>DB202C1F-89A3-4626-BF75-EB235D7476EF</gtr:id><gtr:title>The Function of Vav Family Proteins in Immunity and Tolerance</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G117/424</gtr:grantReference><gtr:abstractText>The immune system has evolved to protect our bodies from the constant attack of harmful micro-organisms. To do this successfully the immune system utilises cells and molecules that convey information about the nature of the attacking micro-organism and employs mechanisms to prevent the immune system from attacking our own cells (tolerance). This information is conveyed into the immune cell by cell-surface receptors that are linked to molecules responsible for signal amplification, interpretation and attenuation (signal transduction). A large number of genes encoding proteins whose function is signal transduction have been discovered, but in many cases little is known regarding their importance or mode of action. One family of genes contributing to these signalling processes in immune cells are the so-called Vav genes of which there are three known members. The experimental approaches described in this fellowship application are designed to establish how the three known Vav genes regulate the function of immune cells. By combining molecular, cellular and whole animal approaches I expect to define the function, mechanism of action and physiological importance of this family of proteins. The results will provide a greater insight into the mechanisms by which the antigen receptor controls immune cell activation and tolerance. This knowledge will contribute to our understanding of the genetics of autoimmunity and may highlight Vav proteins as a point for manipulation during infectious and non-infectious disease.</gtr:abstractText><gtr:technicalSummary>The signalling process activated within B cells as a consequence of antigen encounter determines the outcome of the immune response in terms of tolerance induction, the production of high affinity antibodies and the establishment of immunological memory. My previous work has provided evidence that Vav proteins play an important role in B cell function. This proposal extends these studies to include an investigation into the role of Vav-3 in B cell signalling. Both Vav-1 and Vav-2 are regulators of NFAT dependent transcription and this proposal contains experiments designed to elucidate the molecular mechanisms by which this is mediated. In particular I wish to understand how the Vav Calponin Homology domain regulates antigen receptor elicited calcium flux by identifying proteins that interact with the CH domain. Vav proteins regulate the activity of members of the Rho/Rac family of small GTPases including RhoG. RhoG is thus likely to be an important regulator of lymphocyte development and the immune response. To demonstrate this I propose to establish a mouse strain containing a conditional null mutation of RhoG as well as creating effector domain mutants of RhoG and demonstrating their effect on lymphocyte development and function. An important component of this proposal will be the study of lymphocyte tolerance and immune responses following immunisation using knockout mice lacking combinations of Vav proteins. The overall outcome of these studies will be a fuller understanding of the signalling mechanisms necessary for an immune response.</gtr:technicalSummary><gtr:fund><gtr:end>2008-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1073678</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Institute for Cancer Research</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>collaboration</gtr:description><gtr:id>478D0F83-B506-4610-9228-3D2387DA7A36</gtr:id><gtr:impact>PMID: 19715691 PMID: 16137676</gtr:impact><gtr:outcomeId>E6A5196687A-1</gtr:outcomeId><gtr:piContribution>provided know how and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>collaboration</gtr:description><gtr:id>04ED6E44-6DF3-4B26-BAFF-4C4834F4E40F</gtr:id><gtr:impact>PMID: 19088377</gtr:impact><gtr:outcomeId>FBCA2925E28-1</gtr:outcomeId><gtr:piContribution>provided mutant mice and expertise</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer Research UK London Research Institute (LRI)</gtr:department><gtr:description>collaboration</gtr:description><gtr:id>8CD0D77E-4CA8-4BD8-9A89-A2A4C986CCDA</gtr:id><gtr:impact>PMID: 18191593</gtr:impact><gtr:outcomeId>5BF8C27BEDA-1</gtr:outcomeId><gtr:piContribution>supplied mutant mice</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7350D494-04FA-4963-9B36-EC93CF5EA6EA</gtr:id><gtr:impact>lecture on opening of BI BSU

impressed science minister and other policymakers</gtr:impact><gtr:outcomeId>26CF2A35C2C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>student visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E5889732-BBAD-4129-A921-22C22E922BC8</gtr:id><gtr:impact>We have hosted Da Vinci scholars for six month studenships

Students are exceptional and are keen to pursue PhD studies at our institite but have problems getting stipends-we should fix this!</gtr:impact><gtr:outcomeId>3F17E56BD18</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1D1FBB21-D10E-446B-AC0C-82C77DC9BC6A</gtr:id><gtr:impact>sparked discussion

increased interest in immune system, obesity and the microbiome.</gtr:impact><gtr:outcomeId>4F72351758C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>open day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D8D474DB-718D-41E1-9FFB-279806E6B2FE</gtr:id><gtr:impact>practical demonstrations and participation in a simple experiment

inspired young people</gtr:impact><gtr:outcomeId>73E3072BBF7</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1407230</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Senior Non-Clinical Fellowship</gtr:description><gtr:end>2011-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>39534746-D014-4848-9A54-0859C9156FDD</gtr:id><gtr:outcomeId>7A99E0526D90</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>floxed alleles of zfp36 family generated (three genes)</gtr:description><gtr:id>C72AF08B-2A7A-4D61-9740-1D378B8080B2</gtr:id><gtr:impact>ongoing reserch has revealed phenotypes of potential clinical relevance. mice have been distributed to other researchers</gtr:impact><gtr:outcomeId>4FF390D7B6B</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>mutant mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>conditional mutant mice</gtr:description><gtr:id>BAE1E854-0305-404E-A620-33C25E5F6DB1</gtr:id><gtr:impact>patent application</gtr:impact><gtr:outcomeId>8450FC14DFD</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>mutant mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9FC96DDE-ACDE-4EE7-9273-2818FCF8356C</gtr:id><gtr:title>Requirement of bic/microRNA-155 for normal immune function.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/604e279f7a04382903bd3809bdfc8729"><gtr:id>604e279f7a04382903bd3809bdfc8729</gtr:id><gtr:otherNames>Rodriguez A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>27581AFF6E6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45872D15-1BCE-406D-BE85-68ADBC8FD010</gtr:id><gtr:title>Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4605097239638d5f9ebc7e490f0161fb"><gtr:id>4605097239638d5f9ebc7e490f0161fb</gtr:id><gtr:otherNames>Webb LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>64ADC51BF8E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC36B58C-6C16-4498-9327-D00A86F4CACF</gtr:id><gtr:title>An emerging role of RNA-binding proteins as multifunctional regulators of lymphocyte development and function.</gtr:title><gtr:parentPublicationTitle>Advances in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9780123942999</gtr:isbn><gtr:issn>0065-2776</gtr:issn><gtr:outcomeId>doi_53cfe1fe11f56c13</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E958F6CA-B8D7-489E-8CEE-CA1D8B3A8BE3</gtr:id><gtr:title>Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89c6ac9c125805e49560618d1b91057b"><gtr:id>89c6ac9c125805e49560618d1b91057b</gtr:id><gtr:otherNames>Soond DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14095_25_22611241</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>119CD7D1-1997-431E-AD52-C21BA3ACF5C3</gtr:id><gtr:title>Vav-dependent and vav-independent phosphatidylinositol 3-kinase activation in murine B cells determined by the nature of the stimulus.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>D7168C3C82D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A48E32E-97CD-4D40-97E9-C0D6A60DCA59</gtr:id><gtr:title>Phospholipase C-gamma2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f73bc6ba8c58c13ad3bb0edd44aea4"><gtr:id>15f73bc6ba8c58c13ad3bb0edd44aea4</gtr:id><gtr:otherNames>Caraux A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>B310084D1D1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D12A053-DED4-4853-A6EC-AAC1436BC714</gtr:id><gtr:title>Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals.</gtr:title><gtr:parentPublicationTitle>BMC cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/df5482554290e3068b6b8eef28832d47"><gtr:id>df5482554290e3068b6b8eef28832d47</gtr:id><gtr:otherNames>McKenzie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1471-2121</gtr:issn><gtr:outcomeId>FC1DCE472BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF7571F7-9081-45F8-9805-3003294651BC</gtr:id><gtr:title>Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9b9e40d67743028952b79e07a86e54e"><gtr:id>b9b9e40d67743028952b79e07a86e54e</gtr:id><gtr:otherNames>Arana E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>7BA582928A4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AC5B09D-87C6-4958-8B7F-03E31DEE9356</gtr:id><gtr:title>The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression.</gtr:title><gtr:parentPublicationTitle>Developmental dynamics : an official publication of the American Association of Anatomists</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47fc865bfc3ccc9c42f1787f39b04c44"><gtr:id>47fc865bfc3ccc9c42f1787f39b04c44</gtr:id><gtr:otherNames>Bell SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1058-8388</gtr:issn><gtr:outcomeId>3D797992820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC64A2F8-9A9A-4A09-8211-05DCA6C712E8</gtr:id><gtr:title>Vav1 and Vav2 play different roles in macrophage migration and cytoskeletal organization.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6c96c8d12e7ee810c335094f6b3b34ce"><gtr:id>6c96c8d12e7ee810c335094f6b3b34ce</gtr:id><gtr:otherNames>Wells CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>D3EE7272106</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A1DA2BA-3519-4E16-89F8-1DE64CFBD5E9</gtr:id><gtr:title>Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7f84660b423d6c09271cb9f398505849"><gtr:id>7f84660b423d6c09271cb9f398505849</gtr:id><gtr:otherNames>Suire S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>59465A46D56</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0316D1F1-7051-44E9-96E5-44C589A647C3</gtr:id><gtr:title>BCR activation of PI3K is Vav-independent in murine B cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>77E87F3D339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44B176B8-014F-41F5-B30C-D69B93848005</gtr:id><gtr:title>Synergistic activation of PKD by the B cell antigen receptor and CD19 requires PI3K, Vav1 and PLCgamma.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn><gtr:outcomeId>A21EA985464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6EAC61B3-66DD-4EE6-A3D3-217844546263</gtr:id><gtr:title>Phosphatidylinositol 3-kinase is required for the transcriptional activation of cyclin D2 in BCR activated primary mouse B lymphocytes.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fae32ed4b107ad6e7d35eee8b30ebae"><gtr:id>0fae32ed4b107ad6e7d35eee8b30ebae</gtr:id><gtr:otherNames>Glassford J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>E00C1C4FD91</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3F1C803-F23B-4BCD-A27A-0431CB2505A9</gtr:id><gtr:title>Differential regulation of TCR-mediated gene transcription by Vav family members.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72631dff603ccabe36485c6b0db3cea7"><gtr:id>72631dff603ccabe36485c6b0db3cea7</gtr:id><gtr:otherNames>Zakaria S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>EB48F3FBFF3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FE0A107-0A82-42E1-B18C-D780A625C7AD</gtr:id><gtr:title>Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b18cc7a2f962431c26070c028b18f8"><gtr:id>59b18cc7a2f962431c26070c028b18f8</gtr:id><gtr:otherNames>Condliffe AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>F09468B21AA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B3E3FF2F-B8D1-41B6-A1C7-974E9B928035</gtr:id><gtr:title>Immunological function in mice lacking the Rac-related GTPase RhoG.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>B389733ED06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1806DF45-BF9F-4D0A-8116-6355AE605AE7</gtr:id><gtr:title>The PI3K p110delta is required for down-regulation of RAG expression in immature B cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0448103c15d9a8ea3e8716f47d17ff0"><gtr:id>d0448103c15d9a8ea3e8716f47d17ff0</gtr:id><gtr:otherNames>Llorian M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>6D6EA5ED4B1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>666EB6A4-41F4-4237-943A-77232BB136FC</gtr:id><gtr:title>Vav proteins are required for B-lymphocyte responses to LPS.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f34ac33196d6d843d1ba8762dfbfc53"><gtr:id>0f34ac33196d6d843d1ba8762dfbfc53</gtr:id><gtr:otherNames>Hebeis B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>05085B81A38</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5EFA749-86C9-4B36-A894-7B53E50DA367</gtr:id><gtr:title>A new mechanism of gene regulation mediated by noncoding RNA.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_14095_25_22723637</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB6B7851-B14A-4A42-AEBE-66ED9D1BD126</gtr:id><gtr:title>microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>6FCB8EDE042</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2E12AB6-BB12-4953-90A0-B279D4000BE2</gtr:id><gtr:title>Vav proteins regulate peripheral B-cell survival.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>0610BD00531</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57D938D9-C9E0-4D7A-8F57-F06F7B702E72</gtr:id><gtr:title>The p110delta subunit of phosphoinositide 3-kinase is required for the lipopolysaccharide response of mouse B cells.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9c24d6093b2941388707499496f7269"><gtr:id>b9c24d6093b2941388707499496f7269</gtr:id><gtr:otherNames>Hebeis BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>429E6EEFC74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5CD46C71-3296-4A4B-9F7C-F7E184111D86</gtr:id><gtr:title>Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/029d9cea81210c2fee009df7572b3c3c"><gtr:id>029d9cea81210c2fee009df7572b3c3c</gtr:id><gtr:otherNames>Pearce AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>23DCE0D158F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E89314F-C4C0-4B64-A13C-6EF554BAD00C</gtr:id><gtr:title>Differential requirements of PI3K subunits for BCR or BCR/CD19-induced ERK activation.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>EF0230C6C0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0E48958-051D-4425-AE92-A102E231BC3A</gtr:id><gtr:title>Regulation of lymphocyte development and function by RNA-binding proteins.</gtr:title><gtr:parentPublicationTitle>Current opinion in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0952-7915</gtr:issn><gtr:outcomeId>pm_14095_25_22326859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECCB8979-01F1-417E-8B50-921E5BE0EDD9</gtr:id><gtr:title>The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6816bd5656263b2f08a46c9c38d307eb"><gtr:id>6816bd5656263b2f08a46c9c38d307eb</gtr:id><gtr:otherNames>Kim N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>53513D19C67</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC74BBDC-87E5-4804-B748-52C88CC9EDE8</gtr:id><gtr:title>PLCgamma2 regulates Bcl-2 levels and is required for survival rather than differentiation of marginal zone and follicular B cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47fc865bfc3ccc9c42f1787f39b04c44"><gtr:id>47fc865bfc3ccc9c42f1787f39b04c44</gtr:id><gtr:otherNames>Bell SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>8D1CBBB5D54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7C8E187-B0E6-460D-B1C1-062A98ABA697</gtr:id><gtr:title>The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7049ab5b9b59ba3f8cbf79b761c1402"><gtr:id>c7049ab5b9b59ba3f8cbf79b761c1402</gtr:id><gtr:otherNames>Chen G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>A7039EA1AE7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0629936A-546F-441E-9CD5-EC2DA1FDD667</gtr:id><gtr:title>RhoG regulates the neutrophil NADPH oxidase.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b18cc7a2f962431c26070c028b18f8"><gtr:id>59b18cc7a2f962431c26070c028b18f8</gtr:id><gtr:otherNames>Condliffe AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>F74830B6491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>961C4BEB-00B4-4C8D-ADF0-04618BC5988D</gtr:id><gtr:title>Syk and Slp-76 mutant mice reveal a cell-autonomous hematopoietic cell contribution to vascular development.</gtr:title><gtr:parentPublicationTitle>Developmental cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/da7728b53f645fe4dde07d0c6041ba30"><gtr:id>da7728b53f645fe4dde07d0c6041ba30</gtr:id><gtr:otherNames>Sebzda E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1534-5807</gtr:issn><gtr:outcomeId>A90E31C62BB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G117/424</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>